文献速递精神分裂症与精神病性障碍

精神分裂症患者外周血神经生长因子水平的荟萃分析

A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
PubMed 文献 · Mol Psychiatry · 2017-01-10

该系统综述与荟萃分析纳入13篇文章共1693人,比较精神分裂症患者与健康对照的外周血神经生长因子水平。随机效应模型显示患者NGF水平显著降低(Hedges's g=-0.633,95%CI=-0.948至-0.318,P<0.001),血清和血浆、未用药和用药患者中均降低。

要点

  • 精神分裂症患者外周血NGF水平较健康对照显著降低。
  • 血清和血浆、未用药和用药患者中均观察到NGF降低。
  • 年龄、性别和样本量无调节效应,疾病严重程度可能是混杂因素。

核心结论

  • 精神分裂症患者外周血NGF水平显著降低,支持神经营养因子异常假说。

研究设计与样本

  • 系统检索Pubmed、PsycINFO和Web of Science,纳入13篇文章共1693人,采用随机效应荟萃分析。

主要发现

  • 精神分裂症患者外周血NGF水平较健康对照显著降低(Hedges's g=-0.633,95%CI=-0.948至-0.318,P<0.001)。
  • 血清NGF水平降低(Hedges's g=-0.671,95%CI=-1.259至-0.084,P=0.025)。
  • 血浆NGF水平降低(Hedges's g=-0.621,95%CI=-0.980至-0.261,P<0.001)。
  • 未用药患者NGF水平降低(Hedges's g=-0.670,95%CI=-1.118至-0.222,P=0.003)。
  • 用药患者NGF水平降低(Hedges's g=-0.357,95%CI=-0.592至-0.123,P=0.003)。

关键数值与推荐

  • 年龄、性别和样本量对结局无调节效应。
  • 疾病严重程度可能是荟萃分析的混杂因素。

临床怎么用

  • 外周血NGF水平降低可作为精神分裂症神经营养因子异常的临床证据参考。

局限性

  • 疾病严重程度可能是混杂因素,影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neurotrophins particularly brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are crucial modulators in the neurodevelopment and maintenance of central and peripheral nervous systems. Neurotrophin hypothesis of schizophrenia (SCZ) postulated that the changes in the brains of SCZ patients are the result of disturbances of developing processes involving neurotrophic factors. This hypothesis was mainly supported by the abnormal regulation of BDNF in SCZ, especially the decreased peripheral blood BDNF levels in SCZ patients validated by several meta-analyses. However, the regulation of NGF in SCZ remains unclear because of the inconsistent findings from the clinical studies. Therefore, we undertook, to the best of our knowledge, the first systematic review with a meta-analysis to quantitatively summarize the peripheral blood NGF data in SCZ patients compared with healthy control (HC) subjects. A systematic search of Pubmed, PsycINFO and Web of Science identified 13 articles encompassing a sample of 1693 individuals for the meta-analysis. Random-effects meta-analysis showed that patients with SCZ had significantly decreased peripheral blood levels of NGF when compared with the HC subjects (Hedges's g=-0.633, 95% confidence interval (CI)=-0.948 to -0.318, P<0.001). Subgroup analyses revealed reduced NGF levels both in serum (Hedges's g=-0.671, 95% CI=-1.259 to -0.084, P=0.025) and plasma (Hedges's g=-0.621, 95% CI=-0.980 to -0.261, P<0.001) of the patients, and in drug-free (Hedges's g=-0.670, 95% CI=-1.118 to -0.222, P=0.003) and medicated (Hedges's g=-0.357, 95% CI=-0.592 to -0.123, P=0.003) patients with SCZ. Furthermore, meta-regression analyses showed that age, gender and sample size had no moderating effects on the outcome of the meta-analysis, whereas disease severity might be a confounding factor for the meta-analysis. These results demonstrated that patients with SCZ are accompanied by the decreased peripheral blood NGF levels, strengthening the clinical evidence of an abnormal neurotrophin profile in the patients with SCZ.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Qin XY, Wu HT, Cao C, et al. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia. Mol Psychiatry. 2017. PMID: 28070123. doi:10.1038/mp.2016.235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。